Skip to main content
Log in

Impaired clearance of apoptotic cells in systemic lupus erythematosus: Challenge of T and B cell tolerance

  • Invited Commentary
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Winkler TH, Jahn S, Kalden JR: IgG human monoclonal anti- DNA autoantibodies from patients with systemic lupus erythematosus. Clin Exp Immunol 1991, 85:379–385.

    Article  PubMed  CAS  Google Scholar 

  2. Winkler TH, Fehr H, Kalden JR: Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur J Immunol 1992, 22:1719–1728.

    Article  PubMed  CAS  Google Scholar 

  3. Rekvig O: Polyoma induced autoimmunity to DNA: experimental systems and clinical observations in human SLE. Lupus 1997, 6:325–326.

    PubMed  CAS  Google Scholar 

  4. Moens U, Seternes OM, Hey AW, et al.: In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones. Proc Natl Acad Sci U S A 1995, 92:12393–12397.

    Article  PubMed  CAS  Google Scholar 

  5. Desai-Mehta A, Mao C, Rajagopalan S, et al.: Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 1995, 95:531–541.

    PubMed  CAS  Google Scholar 

  6. Voll RE, Roth EA, Girkontaite I, et al.: Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum 1997, 40:2162–2171.

    Article  PubMed  CAS  Google Scholar 

  7. Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes [see comments]. J Exp Med 1994, 179:1317–1330.

    Article  PubMed  CAS  Google Scholar 

  8. Rosen A, Casciola-Rosen L, Ahearn J: Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 1995, 181:1557–1561.

    Article  PubMed  CAS  Google Scholar 

  9. Utz PJ, Hottelet M, Schur PH, Anderson P: Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997, 185:843–854.

    Article  PubMed  CAS  Google Scholar 

  10. Casiano CA, Ochs RL, Tan EM: Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ 1998, 5:183–190.

    Article  PubMed  CAS  Google Scholar 

  11. Casciola-Rosen L, Andrade F, Ulanet D, et al.: Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999, 190:815–826.

    Article  PubMed  CAS  Google Scholar 

  12. Rutjes SA, Utz PJ, van der Heijden A, et al.: The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis. Cell Death Differ 1999, 6:976–986.

    Article  PubMed  CAS  Google Scholar 

  13. Savill J: Apoptosis in resolution of inflammation. J Leukoc Biol 1997, 61:375–380.

    PubMed  CAS  Google Scholar 

  14. Voll RE, Herrmann M, Roth EA, et al.: Immunosuppressive effects of apoptotic cells [letter]. Nature 1997, 390:350–351.

    Article  PubMed  CAS  Google Scholar 

  15. Fadok VA, Bratton DL, Konowal A, et al.: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998, 101:890–898.

    PubMed  CAS  Google Scholar 

  16. Ponner BB, Stach C, Zoller O, et al.: Induction of apoptosis reduces immunogenicity of human T-cell lines in mice. Scand J Immunol 1998, 47:343–347.

    Article  PubMed  CAS  Google Scholar 

  17. Herrmann M, Zoller OM, Hagenhofer M, et al.: What triggers anti-dsDNA antibodies? Mol Biol Rep 1996, 23:265–267.

    Article  PubMed  CAS  Google Scholar 

  18. Herrmann M, Voll RE, Zoller OM, et al.: Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998, 41:1241–1250.

    Article  PubMed  CAS  Google Scholar 

  19. Herrmann M, Voll RE, Kalden JR: Etiopathogenesis of systemic lupus erythematosus. Immunol Today 2000, 21:424–426.

    Article  PubMed  CAS  Google Scholar 

  20. Rosen A, Casciola-Rosen L: Macromolecular substrates for the ICE-like proteases during apoptosis. J Cell Biochem 1997, 64:50–54.

    Article  PubMed  CAS  Google Scholar 

  21. Melino G, Piacentini M: ‘Tissue’ transglutaminase in cell death: a downstream or a multifunctional upstream effector? FEBS Lett 1998, 430:59–63.

    Article  PubMed  CAS  Google Scholar 

  22. Deng H, Apple R, Clare-Salzler M, et al.: Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med 1993, 178:1675–1680.

    Article  PubMed  CAS  Google Scholar 

  23. Shokat KM, Goodnow CC: Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 1995, 375:334–338.

    Article  PubMed  CAS  Google Scholar 

  24. Carroll MC: The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 1998, 16:545–568.

    Article  PubMed  CAS  Google Scholar 

  25. Camacho SA, Kosco-Vilbois MH, Berek C: The dynamic structure of the germinal center. Immunol Today 1998, 19:511–514.

    Article  PubMed  CAS  Google Scholar 

  26. Korb LC, Ahearn JM: C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 1997, 158:4525–4528.

    PubMed  CAS  Google Scholar 

  27. Mevorach D, Gershov D, Elkon KB: Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998, 188:2313–2320.

    Article  PubMed  CAS  Google Scholar 

  28. Carroll MC: The role of complement in B cell activation and tolerance. Adv Immunol 2000, 74:61–88.

    Article  PubMed  CAS  Google Scholar 

  29. Svensson B: Monocyte in vitro function in systemic lupus erythematosus (SLE), I: a clinical and immunological study. Scand J Rheumatol Suppl 1980, 31:29–41.

    PubMed  CAS  Google Scholar 

  30. Svensson B: Occurrence of deficient monocyte yeast cell phagocytosis in presence of rheumatic sera. Scand J Rheumatol Suppl 1980, 31:21–27.

    PubMed  CAS  Google Scholar 

  31. Hurst NP, Nuki G, Wallington T: Evidence for intrinsic cellular defects of ‘complement’ receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1984, 55:303–312.

    PubMed  CAS  Google Scholar 

  32. Salmon JE, Kimberly RP, Gibofsky A, Fotino M: Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization. J Immunol 1984, 133:2525–2531.

    PubMed  CAS  Google Scholar 

  33. Gaipl US, Kuenkele S, Voll RE, et al.: Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell Death Differ 2001, 8:327–334.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuenkele, S., Beyer, T.D., Voll, R.E. et al. Impaired clearance of apoptotic cells in systemic lupus erythematosus: Challenge of T and B cell tolerance. Curr Rheumatol Rep 5, 175–177 (2003). https://doi.org/10.1007/s11926-003-0061-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-003-0061-1

Keywords

Navigation